HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization of a bicyclic peptide neuropilin-1 (NP-1) antagonist (EG3287) reveals importance of vascular endothelial growth factor exon 8 for NP-1 binding and role of NP-1 in KDR signaling.

Abstract
Neuropilin-1 (NP-1) is a receptor for vascular endothelial growth factor-A165 (VEGF-A165) in endothelial cells. To define the role of NP-1 in the biological functions of VEGF, we developed a specific peptide antagonist of VEGF binding to NP-1 based on the NP-1 binding site located in the exon 7- and 8-encoded VEGF-A165 domain. The bicyclic peptide, EG3287, potently (K(i) 1.2 microM) and effectively (>95% inhibition at 100 microM) inhibited VEGF-A165 binding to porcine aortic endothelial cells expressing NP-1 (PAE/NP-1) and breast carcinoma cells expressing only NP-1 receptors for VEGF-A, but had no effect on binding to PAE/KDR or PAE/Flt-1. Molecular dynamics calculations, a nuclear magnetic resonance structure of EG3287, and determination of stability in media, indicated that it constitutes a stable subdomain very similar to the corresponding region of native VEGF-A165. The C terminus encoded by exon 8 and the three-dimensional structure were both critical for EG3287 inhibition of NP-1 binding, whereas modifications at the N terminus had little effect. Although EG3287 had no direct effect on VEGF-A165 binding to KDR receptors, it inhibited cross-linking of VEGF-A165 to KDR in human umbilical vein endothelial cells co-expressing NP-1, and inhibited stimulation of KDR and PLC-gamma tyrosine phosphorylation, activation of ERKs1/2 and prostanoid production. These findings characterize the first specific antagonist of VEGF-A165 binding to NP-1 and demonstrate that NP-1 is essential for optimum KDR activation and intracellular signaling. The results also identify a key role for the C-terminal exon 8 domain in VEGF-A165 binding to NP-1.
AuthorsHaiyan Jia, Azadeh Bagherzadeh, Basil Hartzoulakis, Ashley Jarvis, Marianne Löhr, Shaheda Shaikh, Rehan Aqil, Lili Cheng, Michelle Tickner, Diego Esposito, Richard Harris, Paul C Driscoll, David L Selwood, Ian C Zachary
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 281 Issue 19 Pg. 13493-13502 (May 12 2006) ISSN: 0021-9258 [Print] United States
PMID16513643 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Peptide Fragments
  • Vascular Endothelial Growth Factor A
  • vascular endothelial growth factor A (138-165)
  • Neuropilin-1
  • Vascular Endothelial Growth Factor Receptor-2
Topics
  • Amino Acid Sequence
  • Animals
  • Cells, Cultured
  • Endothelial Cells (drug effects, metabolism)
  • Humans
  • Neuropilin-1 (antagonists & inhibitors, metabolism)
  • Peptide Fragments (pharmacology)
  • Protein Binding
  • Protein Conformation
  • Signal Transduction
  • Swine
  • Vascular Endothelial Growth Factor A (metabolism, pharmacology)
  • Vascular Endothelial Growth Factor Receptor-2 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: